Axcend
Salt Lake City, US · Founded 2016 · Delaware LLC
Axcend builds compact, portable HPLC (high-performance liquid chromatography) instruments, including the Focus LC line with automated sampling, real-time reaction monitoring, and multi-wavelength UV detection. Its analytical chemistry systems serve pharmaceutical, chemical, and educational customers for lab and production-line analysis.
Founders & leadership
Axcend was founded in 2016 by MILTON L LEE.
ML
MILTON L LEEMANAGER
GD
GLEN D MELLACHIEF EXECUTIVE OFFICER
Board
BD
BRANDON D FUGALMANAGER
CM
CHRISTOPHER M LEEMANAGER
Reported raises · per SEC filings
Form D private placements$7.2M disclosed across 6 of 7 rounds · 2018–2023
▶$660.8KraisedFeb 2023 · 6 investors · Other TechnologyRule 506(b)
▶$660.8KraisedFeb 2023 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher M LeeDirector
- Milton L LeeDirector
- Brandon D FugalDirector
- Brent R KnudsenDirector
- Glen D MellaExecutive Officer
- Curtis B HillDirector
- Offering amount
- $2M
- Amount sold
- $660.8K
- Minimum investment
- $17.4K
- First sale
- Feb 2023
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$750KraisedMar 2021 · 2 investors · Other TechnologyRule 506(b)
▶$750KraisedMar 2021 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Curtis B. HillDirector
- Glen D. MellaExecutive Officer, Director
- Brandon D. FugalDirector
- Christopher M. LeeDirector
- Brent R. KnudsenDirector
- Milton L. LeeDirector
- Offering amount
- $1.4M
- Amount sold
- $750K
- Minimum investment
- $250K
- First sale
- Feb 2021
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedMar 2020 · 2 investors · Other TechnologyRule 506(b)
▶$1.7MraisedMar 2020 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Brandon D FugalDirector
- Christopher M LeeDirector
- Milton L LeeDirector
- Glen D MellaExecutive Officer, Director
- Brent R KnudsenDirector
- Curtis B HillDirector
- Offering amount
- $2M
- Amount sold
- $1.7M
- Minimum investment
- $700K
- First sale
- Mar 2020
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
▶$2.5MraisedMay 2019 · 4 investors · Other TechnologyRule 506(b)
▶$2.5MraisedMay 2019 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Brandon D FugalDirector
- Brent R KnudsenDirector
- Curtis B HillDirector
- Glen D MellaExecutive Officer
- Christopher M LeeDirector
- Milton L LeeDirector
- Offering amount
- $3M
- Amount sold
- $2.5M
- Minimum investment
- $67.4K
- First sale
- May 2019
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b, 4a5
▶$500KraisedDec 2018 · 3 investors · Other TechnologyRule 506(b)
▶$500KraisedDec 2018 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- CURTIS B. HILLDirector
- BRANDON D FUGALDirector
- CHRISTOPHER M LEEDirector
- GLEN D MELLAExecutive Officer, Director
- MILTON L LEEDirector
- Offering amount
- $500K
- Amount sold
- $500K
- Minimum investment
- $100K
- First sale
- Dec 2018
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
▶$1MraisedJun 2018 · 3 investors · Other TechnologyRule 506(b)
▶$1MraisedJun 2018 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- BRANDON D FUGALDirector
- MILTON L LEEDirector
- GLEN D MELLAExecutive Officer
- CHRISTOPHER M LEEDirector
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $150K
- First sale
- Jun 2018
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
▶$400KofferedFeb 2018 · 1 investors · Other TechnologyRule 506(b)
▶$400KofferedFeb 2018 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- BRANDON D FUGALDirector
- CHRISTOPHER M LEEDirector
- MILTON L LEEDirector
- GLEN D MELLAExecutive Officer
- Offering amount
- $400K
- Minimum investment
- $400K
- First sale
- Jan 2018
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapAdarepharmasolutions3 shared keywordsAdare Pharma Solutions is a contract development and manufacturing organization (CDMO) that develops and produces specialized oral-dose and injectable drug delivery systems at cGMP-compliant global manufacturing sites. It also provides in-house regulatory affairs support to help pharmaceutical clients bring products from molecule to market.
Patheon3 shared keywordsPatheon, part of Thermo Fisher Scientific, is a contract development and manufacturing organization (CDMO) that also offers clinical research (CRO) services for biotechnology and pharmaceutical sponsors. It supports drug development from early-stage R&D through clinical supply and commercial manufacturing across a global network of more than 60 sites.
Companies competing with Axcend for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $258.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $291.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2018 | $135K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Axcend do?
- Axcend builds compact, portable HPLC (high-performance liquid chromatography) instruments, including the Focus LC line with automated sampling, real-time reaction monitoring, and multi-wavelength UV detection. Its analytical chemistry systems serve pharmaceutical, chemical, and educational customers for lab and production-line analysis.
- Who founded Axcend?
- Axcend was founded by MILTON L LEE in 2016.
- How much funding has Axcend raised?
- Axcend has disclosed $7.2M raised across 6 of its 7 known rounds.
- Where is Axcend headquartered?
- Axcend is headquartered in Salt Lake City, US.